Erythrina mildbraedii
Erythrina mildbraedii · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Erythrina mildbraedii is a botanical species that has garnered scientific interest due to its diverse bioactive profile. Research has focused on the EtOAc-soluble extracts derived from both the root bark and the stem bark of this plant. These preparations contain significant chemical constituents, including Erythrin B, Eryvarin B, Fraxidin, and Parvisoflavone B. Preliminary studies indicate that these compounds exhibit notable cytotoxic activities. Consequently, the plant shows potential therapeutic promise in addressing metabolic conditions such as obesity and Type 2 diabetes.
- Synonyms
- Erythrina Klainei · Erythrina Buesgenii · 1 more
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Root · Stem
Classification
Synonyms
Erythrina mildbraedii is a botanical species that has historically been associated with several different scientific names. Within taxonomic literature, it is frequently identified by the synonym Erythrina altissima. The plant is also linked to the name Erythrina buesgenii in various botanical records. Furthermore, researchers have occasionally categorized this species under the synonym Erythrina klainei. Understanding these shifting nomenclature relationships is essential for accurate plant identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Erythrina mildbraedii is a distinctive member of the kingdom Plantae. Within this vast biological group, the species is classified under the class Equisetopsida. It belongs to the order Fabales, which connects it to a diverse array of related plants. Moving deeper into its lineage, the plant is a notable representative of the family Fabaceae. Ultimately, it is defined by its specific placement within the genus Erythrina.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Erythrina |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Erythrina mildbraedii is a distinctive plant species with a broad geographical presence across the African continent. Its distribution spans from the eastern reaches of East Tropical Africa, specifically within Uganda, to the diverse landscapes of West Tropical Africa. In the western regions, the species is commonly found throughout Ghana and Guinea. It also maintains a significant presence in the coastal and inland areas of the Ivory Coast and Liberia. This wide range highlights the plant's ability to thrive in various tropical environments across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Erythrina mildbraedii is a self-supporting tree that establishes a commanding presence in its natural habitat. This species is characterized by its impressive stature, reaching a minimum height of 18.28 meters. Its robust growth form allows it to stand tall as a significant feature of the landscape.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Erythrina mildbraedii has emerged as a significant subject of pharmacological interest due to its potent bioactive properties. Recent investigations into the stem bark of this Cameroonian medicinal plant have led to the isolation of novel dimethylpyrano-isoflavones, specifically erymildbraedin A and B. These compounds, along with several other identified isoflavones, demonstrate notable cytotoxic activity against various endocrine cancer cells. Specifically, researchers observed that these substances effectively inhibit the growth of human breast, prostate, and endometrial adenocarcinoma cell lines. This study highlights the potential of the plant's chemical constituents to serve as a foundation for future cancer research and treatment development.
Compounds
Erythrina mildbraedii is a medicinal plant known to host a diverse array of bioactive phytochemicals within its various tissues. Scientific investigations into its root bark have successfully isolated several prenylated flavonoids, including erythrinin B and parvisoflavone B. Furthermore, studies conducted on the stem bark have identified the presence of other significant compounds such as eryvarin B and scandenone. Research also confirms that fraxidin is a constituent found within this complex botanical profile. Together, these chemical relationships highlight the plant's significant potential for pharmacological applications.
Conditions
Erythrina mildbraedii contains prenylated flavonoids that effectively treat PTP1B activity by inhibiting the enzyme in vitro. These bioactive compounds demonstrate therapeutic potential against endocrine cancer cells through significant growth inhibition. Specifically, the plant's extracts are able to treat endometrial adenocarcinoma cells and human breast adenocarcinoma cells. Furthermore, the inhibition of PTP1B activity by its isolated flavonoids suggests a mechanism that may help treat obesity. Together, these findings highlight the diverse medicinal applications of the various isoflavones found within the plant.
Preparations
Erythrina mildbraedii is utilized in various forms for the isolation of bioactive compounds through specific preparation methods. One method involves preparing the plant as an EtOAc-soluble extract of the root bark to identify isoprenylated flavonoids that inhibit PTP1B activity. Additionally, the plant is prepared as stem bark to facilitate the extraction of novel dimethylpyrano-isoflavones. These stem bark derivatives, such as erymildbraedin A and B, are specifically evaluated for their cytotoxic effects on endocrine cancer cells. Consequently, the different preparations of Erythrina mildbraedii serve as critical sources for discovering potential therapeutic agents.
Parts used
Erythrina mildbraedii is a medicinal plant that serves as a rich source of bioactive phytochemicals found within its various structures. Research has specifically identified valuable prenylated flavonoids located in the root bark of the species. These compounds, isolated from the roots, have demonstrated significant potential as inhibitors of protein tyrosine phosphatase-1B. Additionally, the plant's stem bark contains unique dimethylpyrano-isoflavones that exhibit noteworthy cytotoxic properties. Together, these findings highlight how the different parts of Erythrina mildbraedii contribute to its diverse pharmacological profile.